GlassScriptPhysician profile
Helen E Mcintosh
NPI 1306890009
$4,280.53
in general payments reported to CMS, 2019-2025
36 companies · $564 in 2025
The $564 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $300 · 2021: $787 · 2022: $753 · 2023: $782 · 2024: $407 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $662.98 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $517.04 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $483.51 | 2019-2025 | |
| Exeltis, USA INC. | $303.01 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $233.49 | 2023-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $221.51 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $183.78 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $163.88 | 2019-2025 | Acessa Provu System, Novasure |
| Amag Pharmaceuticals, INC. | $149.13 | 2019 | |
| Myovant Sciences INC. | $123.56 | 2021-2022 | |
| Scynexis, INC. | $110.01 | 2022 | |
| Mylan Pharmaceuticals INC. | $102.46 | 2021-2022 | |
| Myriad Women'S Health, INC. | $99.09 | 2023 | Myrisk |
| Organon LLC | $97.83 | 2022-2025 | Nexplanon |
| Millicent US INC | $95.85 | 2021-2025 | Intrarosa, Femring, Femlyv |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $80.56 | 2022-2025 | |
| Amgen INC. | $68.71 | 2019-2021 | |
| Evofem Biosciences, INC. | $63.41 | 2020-2022 | |
| Allergan, INC. | $58.51 | 2019 | |
| Agile Therapeutics, INC. | $57.73 | 2021-2024 | Twirla |
| Daiichi Sankyo INC. | $51.29 | 2020 | |
| Duchesnay USA Incorporated | $48.61 | 2019 | |
| Lupin INC. | $41.23 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $30.43 | 2019 | |
| Dexcom, INC. | $29.43 | 2023 | Dexcom G6 Transmitter |
| Medical Device Business Services, INC. | $26.04 | 2025 | Enseal |
| Roche Diagnostics Corporation | $24.71 | 2019 | |
| Avion Pharmaceuticals | $24.31 | 2019-2021 | |
| Minerva Surgical, INC | $22.03 | 2019-2021 | |
| Lsi Solutions INC | $21.65 | 2024 | Fornisee |
| Smith+Nephew, INC. | $19.37 | 2025 | Pico |
| Radius Health, INC. | $14.89 | 2019 | |
| Axonics, INC. | $13.38 | 2023 | Axonics |
| Exact Sciences Corporation | $13.12 | 2023 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $12.17 | 2019 | |
| Mission Pharmacal Company | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.